Inpharma Weekly

, Volume 765, Issue 1, pp 15–15 | Cite as

Tamoxifen is a contender for a first-line position in estrogen receptor-positive breast cancer

Newsletter Article

Keywords

Breast Cancer Estrogen Receptor Tamoxifen Alopecia Epirubicin 

Copyright information

© Adis International Ltd 1990

Personalised recommendations